Cefathird Suspension
Active ingredient: Cefdinir125mg/5ml
Pack:60ml powder for oral suspension.
Indications:
| Pediatric Patients (Age 6 Months Through 12 Years) |
| Type of infection |
| Acute Bacterial Otitis Media: cause by Haemophilus influenzae (including beta-lactamse producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only) and Moraxella catarrhalis (including beta-lactamase producing strains) |
| Acute Maxillary Sinusitis |
| Pharyngitis/Tonsillitis: cause by Streptococcus pyogenes |
| Uncomplicated Skin and Skin Structures Infections: cause by Staphylococcus aureus (including beta-lactamase producing strains) and Streptococcus pyogenes. |
Cefathird Capsules:
Active ingredient : Cefdinir 300mg.
Pack:10 Hard gelatin capsules.
Indications:
| Adults and Adolescents (Age 13 Years and Older) |
| Type of infection |
| Community-Acquired Pneumonia: cause by Haemophilus influenza, Haemophilus parainfluenzae, Streptococcus pneumoniae and Moraxella catarrhalis. |
| Acute Exacerbations of Chronic Bronchitis: cause by Haemophilus influenza, Haemophilus parainfluenzae, Streptococcus pneumoniae and Moraxella catarrhalis. |
| Acute Maxillary Sinusitis: cause by Haemophilus influenza, Streptococcus pneumoniae and Moraxella catarrhalis |
| Pharyngitis/Tonsillitis: cause by Streptococcus pyogenes |
| Uncomplicated Skin and Skin Structures Infections: cause by Staphylococcus aureus and Streptococcus pyogenes. |
| Acute Bacterial Otitis Media: cause by Haemophilus influenza, Streptococcus pneumoniae and Moraxella catarrhalis. |
